Diabetes

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), describes a sodium-glucose cotransporter-2 inhibitor in a dvm360 interview.

How should diabetic cats with these comorbidities be treated?

Veterinary professionals attending the 97th WVC Annual Conference have the opportunity to learn about the disease and treatment options for small animals.

Early diagnosis and treatment can help manage the disease and improve quality of life for affected patients.

Valerie J. Parker, DVM, DACVIM (SAIM, Nutrition), talked all about body condition score, muscle condition score, and obesity prevention during a lecture at the Fetch Long Beach conference

Vicky Ograin, MBA, RVT, VTS, explained the types of foods that appeal to pets and offered tips for making food more palatable to these animals in a Fetch dvm360 Conference lecture

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City

Karen Roach, RVT, VTS (ECC), will be presenting sessions on emergency care at the 2024 Fetch Coastal conference in Atlantic City, New Jersey.

Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, discusses common adverse effects of SGLT2 inhibitors and clinical signs of eDKA

Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explains how Sodium-Glucose Cotransporter 2 Inhibitors are used to manage diabetes mellitus in cats

Christopher Pachel, DVM, DACVB, CABC, discusses medical concerns that can manifest themselves in a cat’s behavior, ahead of his lecture at Fetch Coastal in Atlantic City

Each article highlights different advancements in the world of veterinary diabetes treatment and management

Education materials and starter kits to help clients manage diabetes in their pets are accessible through the Diabetes PetCare Alliance

Alex Sigmund, DVM, DACVO, discusses health issues that topical steroids and an antiglaucoma therapy can cause, ahead of his lecture at Fetch Kansas City

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

How new medications on the market are improving the lives of cats and pet owners.

Therapeutic success can be maximized through dietary modifications

A new peer-reviewed paper published in BMC Veterinary Research shows the potential veterinary use of weight loss drug implant

Trupanion analyzed over 20 years’ worth of data to identify common concerns for cats

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The program is expected to discuss a new oral hypoglycaemic agent (SGLT2-inhibitor) for management of feline diabetes

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes